tetano
Editor, Senior Moderator
Microbiol Spectr
. 2022 Dec 1;e0446922.
doi: 10.1128/spectrum.04469-22. Online ahead of print.
Clinical SARS-CoV-2 Kinetic Profiles Are Dependent on the Viral Strain and Host Vaccination Status
Manjula Gunawardana[SUP] 1 [/SUP], John M Cortez Jr[SUP] #[/SUP][SUP] 1 [/SUP], Jessica Breslin[SUP] #[/SUP][SUP] 1 [/SUP], Simon Webster[SUP] #[/SUP][SUP] 1 [/SUP], Nash D Rochman[SUP] 2 [/SUP], Peter A Anton[SUP] 1 [/SUP], Marc M Baum[SUP] 1 [/SUP]
Affiliations
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection kinetics in a real-world, clinical setting represent a knowledge gap in understanding the underlying coronavirus disease 2019 (COVID-19) pathogenesis. There are scant reports of the dynamics describing the two principal components of the viral life cycle, namely, the rapid proliferation and slower clearance phases. Here, we present results from an ongoing workplace clinical surveillance study during which two vaccinated participants became infected with SARS-CoV-2 Omicron variant (BA.1. lineage). The subjects were followed longitudinally with high temporal resolution, allowing the kinetics of both viral phases to be characterized. The viral doubling times in the proliferation phase (3.3 to 3.5 h) and maximum measured viral loads were similar to those observed for unvaccinated individuals infected with an earlier SARS-CoV-2 strain. However, the clearance phase was much shorter in the current study and unexpectedly displayed a multimodal profile. Longitudinal whole-genome SARS-CoV-2 sequencing identified a stable mutation that arose in one of the participants over the 2-week period of positivity. Our small study provides rare insight into the clinical SARS-CoV-2 dynamics, with significance for public health measures and the biology underlying COVID-19. IMPORTANCE We are conducting an ongoing SARS-CoV-2 workplace clinical study based on frequent, longitudinal disease surveillance of staff and household members. Here, we investigated the viral dynamics in two recently vaccinated participants who became infected with the same Omicron variant of SARS-CoV-2. Because the subjects were enrolled in our study, we were able to track the entire viral life cycle with high temporal resolution, with samples collected every 12 h. Surprisingly, the short viral proliferation phase and maximum viral loads in nasal swab samples were similar to our previous observations with unvaccinated participants and an earlier viral strain. However, the decay phase, indicative of viral clearance, was much shorter here. Our results provide a rare, real-world glimpse of the clinical SARS-CoV-2 replication kinetics, potentially impacting immediate therapies and awareness of earlier and greater transmission potential.
Keywords: SARS-CoV-2 kinetics; proliferation phase; viral dynamics; workplace surveillance clinical study.
. 2022 Dec 1;e0446922.
doi: 10.1128/spectrum.04469-22. Online ahead of print.
Clinical SARS-CoV-2 Kinetic Profiles Are Dependent on the Viral Strain and Host Vaccination Status
Manjula Gunawardana[SUP] 1 [/SUP], John M Cortez Jr[SUP] #[/SUP][SUP] 1 [/SUP], Jessica Breslin[SUP] #[/SUP][SUP] 1 [/SUP], Simon Webster[SUP] #[/SUP][SUP] 1 [/SUP], Nash D Rochman[SUP] 2 [/SUP], Peter A Anton[SUP] 1 [/SUP], Marc M Baum[SUP] 1 [/SUP]
Affiliations
- PMID: 36453916
- DOI: 10.1128/spectrum.04469-22
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection kinetics in a real-world, clinical setting represent a knowledge gap in understanding the underlying coronavirus disease 2019 (COVID-19) pathogenesis. There are scant reports of the dynamics describing the two principal components of the viral life cycle, namely, the rapid proliferation and slower clearance phases. Here, we present results from an ongoing workplace clinical surveillance study during which two vaccinated participants became infected with SARS-CoV-2 Omicron variant (BA.1. lineage). The subjects were followed longitudinally with high temporal resolution, allowing the kinetics of both viral phases to be characterized. The viral doubling times in the proliferation phase (3.3 to 3.5 h) and maximum measured viral loads were similar to those observed for unvaccinated individuals infected with an earlier SARS-CoV-2 strain. However, the clearance phase was much shorter in the current study and unexpectedly displayed a multimodal profile. Longitudinal whole-genome SARS-CoV-2 sequencing identified a stable mutation that arose in one of the participants over the 2-week period of positivity. Our small study provides rare insight into the clinical SARS-CoV-2 dynamics, with significance for public health measures and the biology underlying COVID-19. IMPORTANCE We are conducting an ongoing SARS-CoV-2 workplace clinical study based on frequent, longitudinal disease surveillance of staff and household members. Here, we investigated the viral dynamics in two recently vaccinated participants who became infected with the same Omicron variant of SARS-CoV-2. Because the subjects were enrolled in our study, we were able to track the entire viral life cycle with high temporal resolution, with samples collected every 12 h. Surprisingly, the short viral proliferation phase and maximum viral loads in nasal swab samples were similar to our previous observations with unvaccinated participants and an earlier viral strain. However, the decay phase, indicative of viral clearance, was much shorter here. Our results provide a rare, real-world glimpse of the clinical SARS-CoV-2 replication kinetics, potentially impacting immediate therapies and awareness of earlier and greater transmission potential.
Keywords: SARS-CoV-2 kinetics; proliferation phase; viral dynamics; workplace surveillance clinical study.